Ceflaro 600mg IV Injection (1s)

Description

Ceflaro is an intravenous antibacterial injection containing ceftaroline fosamil, a broad-spectrum cephalosporin antibiotic. It is used under medical supervision for susceptible serious bacterial infections, including certain skin and soft-tissue infections and community-acquired bacterial pneumonia.

• Manufacturer Name: Curexa Health (Pvt) Ltd
• Drug Class: Fifth-generation cephalosporin antibiotic
• Dosage Form: Intravenous Injection
• Storage: Store the unopened vial at controlled room temperature and protect it from light. Reconstituted and diluted solutions should be handled and stored according to the product insert or hospital pharmacy instructions.
• Pack Size: Pack of 1

Ceflaro 600mg IV Injection (1s) Available Online in Pakistan

Dwatson offers Ceflaro 600mg IV Injection (1s) at Rs.4290, with fast, discreet delivery across Pakistan.

Ingredients

• Ceftaroline fosamil 600 mg

Benefits

• Treatment of susceptible acute bacterial skin and skin-structure infections.
• Treatment of susceptible community-acquired bacterial pneumonia.
• May be used for other serious susceptible infections only when specifically prescribed by a specialist.

Usage & Safety

For Adult

• The usual adult dose is 600 mg administered by intravenous infusion every 12 hours, generally over 5 to 60 minutes.
• Treatment duration is commonly 5 to 14 days, depending on the infection and clinical response.
• Dosage adjustment is required in patients with moderate or severe renal impairment or those receiving dialysis.
• Administration must be performed by qualified healthcare personnel; the dose and duration should be determined by the treating physician.

For Children

• Use in children should be prescribed by a pediatrician or infectious-disease specialist.
• For children from 2 months to less than 2 years, dosing is generally weight-based and may be given every 8 hours.
• For children from 2 months to less than 18 years, weight-based dosing is used; doses and maximum amounts vary by age, weight, infection, and kidney function.
• Safety and dosing in neonates and infants younger than 2 months require specialist assessment.
• Renal impairment requires pediatric dose adjustment.

Side Effects

• Common effects include diarrhea, nausea, vomiting, headache, rash, itching, and infusion-site reactions.
• Laboratory changes may include increased liver enzymes, reduced white blood-cell count, neutropenia, or positive direct Coombs test.
• Serious reactions may include severe allergy, anaphylaxis, angioedema, severe skin reactions, seizures, severe persistent diarrhea, or significant blood-count abnormalities.
• Report breathing difficulty, facial swelling, widespread blistering rash, unusual bruising, or severe diarrhea immediately.

Contraindications

• Do not use in patients with a history of serious allergic reaction to ceftaroline, other cephalosporins, or severe immediate hypersensitivity to other beta-lactam antibiotics.
• Use cautiously in patients with a history of penicillin allergy or other drug allergies.
• Use cautiously and adjust the dose in renal impairment.
• Seek medical attention for severe or persistent diarrhea, as antibiotic-associated colitis may occur.
• Prolonged treatment may require monitoring for blood-count abnormalities, liver effects, and superinfection.

Precautions & Warnings

• Probenecid may increase ceftaroline exposure and is generally avoided unless specifically directed by a physician.
• Other medicines that affect kidney function may increase the risk of accumulation or adverse effects; renal function should be monitored.
• Tell the doctor about all prescription medicines, over-the-counter medicines, and herbal products before treatment.
• No clinically important food interaction is expected because this medicine is given intravenously.

Pregnancy

• Pregnancy data are limited; use during pregnancy only when clearly needed and when the expected benefit outweighs potential risk.
• Discuss pregnancy, planned pregnancy, or breastfeeding with the treating physician before administration.
• Ceftaroline is generally considered compatible with breastfeeding, but the infant should be monitored for diarrhea, thrush, rash, or other unusual symptoms.